Will GEO Group report FY2026 adjusted EBITDA at or above $490 million?

FY2025 EBITDA was $464M with essentially flat growth (+0.2%) despite 8.7% revenue growth — indicating margin pressure absorbed the entire top-line gain. Reaching $490M requires $26M incremental EBITDA (+5.6%). Revenue growth to $2.9B+ should help, but ISAP repricing (margins from 50% to 42.5%) on the highest-margin business creates a meaningful headwind. Start-up costs from newly activated facilities and Florida DOC contracts add to H2 margin pressure. CapEx reduction ($120-155M vs $200M+) helps free cash flow but doesn't directly affect EBITDA. The key question is whether volume growth can overcome margin compression.

The $490M floor requires 5.6% EBITDA growth on guided 10-18% revenue growth, implying margin can decline slightly and still hit the target. Q4 2025 EBITDA of $126M annualizes to $504M, above the guidance floor. However, Q1 is guided at $107-112M (seasonal trough), resetting the annualized trajectory lower. The back-half margin normalization assumption is critical — if start-up costs are absorbed as expected, H2 should see margin expansion. But ISAP repricing is structural, not seasonal. Moderate confidence in hitting the floor.

If we take Q1 at $110M (midpoint) and assume Q2-Q4 average at $127M (matching Q4 2025), full-year EBITDA would be $491M — barely above the floor. This suggests the $490M guidance floor is actually quite tight, not conservative. Management may have set a realistic floor rather than a sandbagged number. The skip tracing contribution ($60M revenue at assumed 15-20% margin) adds $9-12M EBITDA. Florida DOC ($100M annualized, H2 only = $50M revenue at startup margins) adds limited EBITDA. Net assessment: achievable but with less cushion than the revenue target.

Management guided $490-510M, and their Q4 2025 EBITDA of $126M demonstrates the earnings power exists at current scale. Revenue growth to $2.9B+ with even slight margin improvement would exceed $490M. ISAP margin compression is a headwind but ISAP is one segment — the facility business (Secure Services) drives the majority of EBITDA and benefits from high occupancy at record census levels. Fixed-cost leverage on high-occupancy facilities should support EBITDA growth even with ISAP margin pressure.

The flat EBITDA in FY2025 despite 8.7% revenue growth is the most concerning data point. If the same dynamic repeats — revenue growing but margins compressing — $490M would be difficult. However, FY2025 had specific one-time margin headwinds (facility activations, ISAP repricing transition) that should not repeat at the same magnitude. With CapEx declining and volumes stabilizing, operating leverage should improve. But this is a closer call than the revenue market.

The guidance floor of $490M is the management's own estimate for the low-end scenario. Management has visibility into their cost structure, ISAP repricing impact, and start-up costs. They set the floor knowing these headwinds. Unless there's an unanticipated cost shock (government shutdown delaying revenue while costs continue), $490M should be achievable. The wider question is whether $490M is conservative or tight — my assessment is it's realistic rather than sandbagged.

Management guided $490-510M with Q4 2025 at $126M demonstrating the run rate. Revenue growth should drive volume-based EBITDA improvement. ISAP repricing is a headwind but manageable. 68% reflects achievable floor with some execution risk.

FY2025 flat EBITDA despite revenue growth is a warning sign. ISAP margin compression and start-up costs could repeat the dynamic. The $490M floor is tight not conservative. 61% reflects meaningful execution risk.

Balance of factors: revenue growth supports higher EBITDA, but margin headwinds (ISAP, start-ups) constrain the upside. $490M is achievable with normal execution. 64% probability with risk skewed to the downside from margin compression.